Search :

Research

Specific Research Goals


 From 2009 to 2012, AllerGen seeks to invest in nationally networked research teams deomnstrating excellence, productivity and offering unique capacity building opportunities,  as well as in research that build upson and extend exisiting AllerGen and partner investment with potential to accelerate social and economic impact through application of research resutls to real world problems and challenges faced by partner organizations, sectors of the Canadian economy and/or society.

AllerGen research priorities include three research foci of strategic importance to the generation of new knowledge with potential for social and economic impact in the area of allergic and related immune disease.

1. Programme A – Gene-Environment Interactions Strategic Focus: Genetics, environmental exposures, and gene-environment interactions in allergy and asthma  

  

2. Programme B – Diagnostics and Therapeutics

Strategic Focus: Biomarkers, immune monitoring and drug development/discovery

  

3. Programme C – Public Health, Ethics, Policy and Society

Strategic Focus: Allergic disease management and surveillance

 

In addition, four cross-programmatic, multidisciplinary research thrusts fostered by AllerGen since 2005 are continuing research investment priorities for 2009-2012.

Cross-programmatic Research teams in priority areas:

Established Cross-programmatic Teams

4. The Canadian Healthy Infant Longitudinal Development (CHILD) Study

5. Food Allergy and Anaphylaxis

 

Emerging Cross-programmatic Teams

6. Mind-Body Interactions and Allergic Disease

7. Occupational and Work-related Allergy and Asthma

 

Funding research projects leading to social and economic benefits to Canada is a priority of both the NCE program and AllerGen. Knowledge translation is the all-important link between discovery and development. It is the bridge between the lab and real life.

Translational AllerGen research aims to transform scientific discoveries arising from the laboratory, clinic, or population studies into clinical applications to reduce the incidence, morbidity, mortality and social and economic burden of allergies, asthma and related immune diseases.

Translational research typically looks at two areas of translation. The first is the process of applying discoveries generated during research in the laboratory and preclinical studies, to the development of trials and studies in humans. The second area of translation concerns research aimed at enhancing the adoption of best practices in the community.